Four PM
ArchiveTopDiscussionAbout
Holding the media to a higher standard when it comes to cannabis
Matthew O'Brien
Feb 24CommentShare
Why Weedmaps, LinkedIn, Clubhouse, Twitter & Leafly are all positioned to benefit from the continued rise of cannabis.
Matthew O'Brien and Daniel Elkind
Feb 22CommentShare
Hexo agrees to purchase struggling Canadian cannabis company Zenabis in an all-stock transaction
Matthew O'Brien
Feb 17CommentShare
How the downregulation of our CB1 receptors may be responsible for the ever-increasing demand for high THC cannabis
Matthew O'Brien
Feb 16CommentShare
A turning point in the Canadian cannabis industry as sales in the legal market surpass the illicit market
Matthew O'Brien and Daniel Elkind
Feb 12CommentShare
How one company's explicit focus on medical cannabis paid off
Matthew O'Brien
Feb 10CommentShare
It seems increasingly likely that the U.S. will legalize cannabis on a federal level.
Matthew O'Brien
Feb 8CommentShare
Cannabis 2.0
Matthew O'Brien
Feb 3Comment 3Share
"The industry is beautiful chaos; start-ups servicing start-ups, in a start-up industry."
Matthew O'Brien
Feb 1CommentShare
"The biggest misconception, from an outsiders’ perspective, is that India is an emerging market and that cannabis and its use in medicine is somehow a …
Matthew O'Brien
Jan 29CommentShare
"The fact that there is now a clear path to legalization, whether it be in two years or three years, is huge."
Matthew O'Brien
Jan 28CommentShare
Why Dutchie, Pistil Data, Elevated Signals, LeafLink, and Greenline POS are here to stay
Matthew O'Brien
Jan 27CommentShare
© 2021 Four PM. See privacy, terms and information collection notice
Publish on Substack